{"id":51917,"date":"2022-12-13T15:02:19","date_gmt":"2022-12-13T14:02:19","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\/"},"modified":"2022-12-13T15:02:19","modified_gmt":"2022-12-13T14:02:19","slug":"alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\/","title":{"rendered":"Alight Launches Targeted Offerings for Behavioral Health and Cancer to Address Top Healthcare Challenges"},"content":{"rendered":"<div>\n<p>\n<i>Built on Alight\u2019s existing deep clinical capabilities, robust analytics and consumer-centered content, two new comprehensive products enable employers to take a condition-specific approach to providing personalized support to employees<\/i>\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221213005129\/en\/826946\/5\/Alight_Logo_RGB_Black%281%29.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221213005129\/en\/826946\/21\/Alight_Logo_RGB_Black%281%29.jpg\"><\/a><\/p>\n<p>LINCOLNSHIRE, Ill.&#8211;(BUSINESS WIRE)&#8211;Alight, Inc. (NYSE: ALIT), a leading cloud-based human capital technology and services provider, is redefining the end-to-end healthcare benefits experience and driving improvements in outcomes through two new condition-specific products, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.alight.com%2Fsolutions%2Fhealth-benefits%2Fcancer-guidance&amp;esheet=53045843&amp;newsitemid=20221213005129&amp;lan=en-US&amp;anchor=Alight+Cancer+Guidance&amp;index=1&amp;md5=74ad46405f4c76493859a930bd108001\" rel=\"nofollow noopener\" shape=\"rect\">Alight Cancer Guidance<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.alight.com%2Fsolutions%2Fhealth-benefits%2Fbehavioral-health-guidance&amp;esheet=53045843&amp;newsitemid=20221213005129&amp;lan=en-US&amp;anchor=Alight+Behavioral+Health+Guidance&amp;index=2&amp;md5=18a019171412cedd4bebd12a61af4127\" rel=\"nofollow noopener\" shape=\"rect\">Alight Behavioral Health Guidance<\/a>, to help employers focus on critical needs within their populations. Available through the Alight Worklife<sup>\u00ae<\/sup> platform, these products can be seamlessly integrated into employers\u2019 existing portfolios to enable employers to build a healthier workforce by providing condition-specific resources.\n<\/p>\n<p>\nAlight Cancer Guidance addresses two critical issues, inequity in access to top cancer expertise and support, and the rise in new and late-stage diagnoses. For example, populations in rural areas <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5879727%2F&amp;esheet=53045843&amp;newsitemid=20221213005129&amp;lan=en-US&amp;anchor=see+12%25+higher+mortality+rates&amp;index=3&amp;md5=8d9eaa55cb9595556ffe7a1e241990f4\" rel=\"nofollow noopener\" shape=\"rect\">see 12% higher mortality rates<\/a> from cancers that can be prevented by screening compared to those in metropolitan areas and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.businessgrouphealth.org%2Fen%2Fwho%2520we%2520are%2Fnewsroom%2Fpress%2520releases%2F2023%2520lehcspds&amp;esheet=53045843&amp;newsitemid=20221213005129&amp;lan=en-US&amp;anchor=41%25+of+employers&amp;index=4&amp;md5=85b87a8986a5ce50ef95b86f29ec1cdb\" rel=\"nofollow noopener\" shape=\"rect\">41% of employers<\/a> expect to see a rise in late-stage cancers in 2023 due to missed cancer screenings in 2020 alone (<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fjamanetwork.com%2Fjournals%2Fjamaoncology%2Ffullarticle%2F2778916&amp;esheet=53045843&amp;newsitemid=20221213005129&amp;lan=en-US&amp;anchor=an+estimated+9.4M&amp;index=5&amp;md5=7b9964672ede261e0044e876a2165b54\" rel=\"nofollow noopener\" shape=\"rect\">an estimated 9.4M<\/a>). With targeted identification and outreach, Alight Cancer Guidance provides the urgently needed, trusted guidance and personalized support to employees facing any type or stage of cancer.\n<\/p>\n<p>\nWith Alight Behavioral Health Guidance, organizations can address the behavioral health crisis that is impacting lives across the country and the key barriers that stand in the way of participants finding the right care and the support they need to continue healing. The service connects individuals and families to Alight\u2019s resources with behavioral health expertise, who will work with them to help them better understand their symptoms, any diagnoses, and potential next steps. Participants will receive explanations of treatments, medications, and provider types that might be options, while finding quality providers and facilities specialized in their needs. Alight will also collaborate and coordinate with partners across the employers\u2019 benefits ecosystem.\n<\/p>\n<p>\n\u201cWe hear from our clients regularly about the serious barriers their people face when it comes to finding the right oncology and behavioral health care,\u201d said Colin Brennan, chief customer officer and head of healthcare navigation solutions at Alight. \u201cThese new offerings provide a targeted and accessible way for organizations to respond to top healthcare pain points employees are facing and provide them with critical support in their greatest time of need.\u201d\n<\/p>\n<p>\nStanding behind these products is Alight\u2019s Medical Ally team, who bring more than 20 years of experience in providing skilled, compassionate guidance and support.\n<\/p>\n<p>\n\u201cWhen it comes to addressing behavioral health needs and navigating a cancer diagnosis, employees face a variety of barriers that are both emotionally and structurally rooted,\u201d said Bipin Mistry, chief medical officer at Alight. \u201cOur Medical Allies offer specialized and advanced support, contextualized to the unique needs of the individual participants we serve, which is critically important to driving better outcomes.\u201d\n<\/p>\n<p>\nTo learn more about Alight Cancer Guidance and Alight Behavioral Health Guidance, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.alight.com&amp;esheet=53045843&amp;newsitemid=20221213005129&amp;lan=en-US&amp;anchor=Alight.com&amp;index=6&amp;md5=60e57da3d1fe60a21f3680ca75fb6a2e\" rel=\"nofollow noopener\" shape=\"rect\">Alight.com<\/a>.\n<\/p>\n<p>\n<b>About Alight Solutions<\/b>\n<\/p>\n<p>\nAlight is a leading cloud-based human capital technology and services provider that powers confident health, wealth and wellbeing decisions for 36 million people and dependents. Our Alight Worklife\u00ae platform combines data and analytics with a simple, seamless user experience. Supported by our global delivery capabilities, Alight Worklife is transforming the employee experience for people around the world. With personalized, data-driven health, wealth, pay and wellbeing insights, Alight brings people the security of better outcomes and peace of mind throughout life\u2019s big moments and most important decisions. Learn how Alight unlocks growth for organizations of all sizes at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Falight.com%2F&amp;esheet=53045843&amp;newsitemid=20221213005129&amp;lan=en-US&amp;anchor=alight.com&amp;index=7&amp;md5=613ee4f3a2c8f096170160886c993b91\" rel=\"nofollow noopener\" shape=\"rect\">alight.com<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nMariana Fischbach<br \/>\n<br \/><a target=\"_blank\" href=\"mail&#116;&#111;&#58;&#109;&#97;&#x72;&#x69;&#x61;&#x6e;&#x61;&#x2e;&#x66;isch&#98;&#97;&#99;&#104;&#64;&#x61;&#x6c;&#x69;&#x67;&#x68;&#x74;&#x2e;&#x63;om\" rel=\"nofollow noopener\" shape=\"rect\">&#x6d;&#x61;&#x72;&#105;&#97;&#110;a&#46;&#x66;&#x69;&#x73;&#x63;&#104;&#98;ac&#x68;&#x40;&#x61;&#x6c;&#105;&#103;ht&#x2e;&#x63;&#x6f;&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Built on Alight\u2019s existing deep clinical capabilities, robust analytics and consumer-centered content, two new comprehensive products enable employers to take a condition-specific approach to providing personalized support to employees LINCOLNSHIRE, Ill.&#8211;(BUSINESS WIRE)&#8211;Alight, Inc. (NYSE: ALIT), a leading cloud-based human capital technology and services provider, is redefining the end-to-end healthcare benefits experience and driving improvements in &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-51917","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Alight Launches Targeted Offerings for Behavioral Health and Cancer to Address Top Healthcare Challenges - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alight Launches Targeted Offerings for Behavioral Health and Cancer to Address Top Healthcare Challenges - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Built on Alight\u2019s existing deep clinical capabilities, robust analytics and consumer-centered content, two new comprehensive products enable employers to take a condition-specific approach to providing personalized support to employees LINCOLNSHIRE, Ill.&#8211;(BUSINESS WIRE)&#8211;Alight, Inc. (NYSE: ALIT), a leading cloud-based human capital technology and services provider, is redefining the end-to-end healthcare benefits experience and driving improvements in ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-13T14:02:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221213005129\/en\/826946\/21\/Alight_Logo_RGB_Black%281%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Alight Launches Targeted Offerings for Behavioral Health and Cancer to Address Top Healthcare Challenges\",\"datePublished\":\"2022-12-13T14:02:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\\\/\"},\"wordCount\":613,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221213005129\\\/en\\\/826946\\\/21\\\/Alight_Logo_RGB_Black%281%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\\\/\",\"name\":\"Alight Launches Targeted Offerings for Behavioral Health and Cancer to Address Top Healthcare Challenges - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221213005129\\\/en\\\/826946\\\/21\\\/Alight_Logo_RGB_Black%281%29.jpg\",\"datePublished\":\"2022-12-13T14:02:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221213005129\\\/en\\\/826946\\\/21\\\/Alight_Logo_RGB_Black%281%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221213005129\\\/en\\\/826946\\\/21\\\/Alight_Logo_RGB_Black%281%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alight Launches Targeted Offerings for Behavioral Health and Cancer to Address Top Healthcare Challenges\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alight Launches Targeted Offerings for Behavioral Health and Cancer to Address Top Healthcare Challenges - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\/","og_locale":"en_US","og_type":"article","og_title":"Alight Launches Targeted Offerings for Behavioral Health and Cancer to Address Top Healthcare Challenges - Pharma Trend","og_description":"Built on Alight\u2019s existing deep clinical capabilities, robust analytics and consumer-centered content, two new comprehensive products enable employers to take a condition-specific approach to providing personalized support to employees LINCOLNSHIRE, Ill.&#8211;(BUSINESS WIRE)&#8211;Alight, Inc. (NYSE: ALIT), a leading cloud-based human capital technology and services provider, is redefining the end-to-end healthcare benefits experience and driving improvements in ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\/","og_site_name":"Pharma Trend","article_published_time":"2022-12-13T14:02:19+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221213005129\/en\/826946\/21\/Alight_Logo_RGB_Black%281%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Alight Launches Targeted Offerings for Behavioral Health and Cancer to Address Top Healthcare Challenges","datePublished":"2022-12-13T14:02:19+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\/"},"wordCount":613,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221213005129\/en\/826946\/21\/Alight_Logo_RGB_Black%281%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\/","url":"https:\/\/pharma-trend.com\/en\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\/","name":"Alight Launches Targeted Offerings for Behavioral Health and Cancer to Address Top Healthcare Challenges - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221213005129\/en\/826946\/21\/Alight_Logo_RGB_Black%281%29.jpg","datePublished":"2022-12-13T14:02:19+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221213005129\/en\/826946\/21\/Alight_Logo_RGB_Black%281%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221213005129\/en\/826946\/21\/Alight_Logo_RGB_Black%281%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/alight-launches-targeted-offerings-for-behavioral-health-and-cancer-to-address-top-healthcare-challenges\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Alight Launches Targeted Offerings for Behavioral Health and Cancer to Address Top Healthcare Challenges"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51917","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51917"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51917\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51917"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51917"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51917"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}